Reason for withdrawal from publication
This review has been superseded by three reviews that have been published as: Graves P, Gelband H. Vaccines for preventing malaria (SPf66). Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD005966. DOI: 10.1002/14651858.CD005966.
Graves P, Gelband H. Vaccines for preventing malaria (blood‐stage). Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD006199. DOI: 10.1002/14651858.CD006199.
Graves P, Gelband H. Vaccines for preventing malaria (pre‐erythrocytic). Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD006198. DOI: 10.1002/14651858.CD006198.
Vaccines for preventing malaria (SPf66) published in Issue 2, 2006; Vaccines for preventing malaria (blood‐stage); and Vaccines for preventing malaria (pre‐erythrocytic) published in Issue 4, 2006.
The editorial group responsible for this previously published document have withdrawn it from publication.
Keywords: Adult; Humans; Recombinant Proteins; Antigens, Protozoan; Antigens, Protozoan/immunology; Malaria; Malaria/prevention & control; Malaria Vaccines; Malaria Vaccines/therapeutic use; Malaria, Falciparum; Malaria, Falciparum/prevention & control; Protozoan Proteins; Protozoan Proteins/immunology; Protozoan Proteins/therapeutic use; Randomized Controlled Trials as Topic; Vaccines, Synthetic; Vaccines, Synthetic/therapeutic use
What's new
| Date | Event | Description |
|---|---|---|
| 27 November 2019 | Amended | Contact details updated. |
History
Protocol first published: Issue 1, 1995 Review first published: Issue 2, 1996
| Date | Event | Description |
|---|---|---|
| 9 November 2008 | Amended | Converted to new review format. |
| 19 August 2006 | Amended | This review has been divided into three separate Cochrane Reviews: Vaccines for preventing malaria (blood‐stage); Vaccines for preventing malaria (pre‐erythrocytic); Vaccines for preventing malaria (SPf66). |
| 20 November 2002 | New search has been performed | Five new trials have been added to this review. One trial was of a vaccine type (SPf66) included in previous reviews. Trials of two new vaccines have also been included: two trials of the sporozoite vaccine RTS,S and two trials of the asexual stage vaccine MSP/RESA. For the first time, we include trials which used artificial challenge in a laboratory situation as well as field trials using natural challenge. |
| 12 October 2002 | New citation required and conclusions have changed | Substantive amendment |
Sources of support
Internal sources
Liverpool School of Tropical Medicine, UK.
External sources
Department for International Development, UK.
European Commission (Development Directorate XII), Belgium.
Withdrawn from publication for reasons stated in the review